Johns Hopkins Medicine International and National Healthcare Group Expand Joint Venture


Johns Hopkins Medicine International (JHI) and the National Healthcare Group (NHG) announced that their 20-year partnership has progressed to a new phase, with their Johns Hopkins Singapore International Medical Centre (JHSIMC) joint venture evolving into the new NHG-Johns Hopkins Singapore Institute.

With this development, JHI and NHG have now re-envisioned their future to include joint research collaborations, development of new capabilities in medical oncology and other disciplines, as well as knowledge-sharing projects.

When NHG and JHI started their health care joint venture two decades ago, both organizations shared a common vision to advance cancer care in Singapore. With this vision met, oncology services and specialized staff from JHSIMC have transitioned to Tan Tock Seng Hospital (TTSH), the flagship of NHG—one of the largest public health care groups in Singapore. This transition integrates care for patients and focuses on the population health needs for Singapore.

“The partnership between Johns Hopkins Medicine International and NHG is an established 20-year relationship. Our health care professionals in TTSH have had the opportunity to learn and share best practices from Johns Hopkins Medicine, a global leader in oncology. With this oncology service now transitioned to TTSH, the range of medical offerings expands to benefit our patients and Singaporeans needing care.

The formation of the new institute is a natural progression and will encourage our health care professionals to pursue related fields of collaborative research, training and education to better meet our population health needs. We welcome all JHSIMC medical, nursing and administrative staff to the NHG family,” says Professor Philip Choo, Group Chief Executive Officer, National Healthcare Group.

Pamela Paulk, President of Johns Hopkins Medicine International, says, “Right from the beginning, our collective goal has been to contribute sustainable solutions for the oncology needs of Singapore, from targeted research to specialized care delivery. With this goal accomplished, we are proud to officially transition these solutions to Tan Tock Seng Hospital and NHG, to celebrate our extraordinary joint accomplishments and map out this next chapter for our joint venture in Singapore.”

The first private hospital in Singapore to be awarded Joint Commission International accreditation in 2004, Johns Hopkins Singapore International Medical Centre developed a robust oncology program and suite of services for Singaporean patients, earning a global reputation with patients from more than 25 countries during its operating period of nearly 20 years.

It annually hosted more than 100 medical students, residents, fellows, nursing students and other allied health professionals for education and training, and became the first Accreditation Council for Graduate Medical Education – International oncology training program in Singapore.

Johns Hopkins Singapore researchers led the initial research and work on a number of drugs that are now the standard treatment for various cancers, conducted more than 120 medical oncology studies and published more than 100 oncology papers in collaboration with Johns Hopkins in the United States. This collaboration will continue under the new NHG-Johns Hopkins Singapore Institute.

About Johns Hopkins Medicine International
JHI facilitates the global expansion of the Johns Hopkins Medicine mission: to improve the health of the community and the world by setting the standard of excellence in medical education, research and clinical care. JHI provides personalized, culturally appropriate care for patients traveling to Johns Hopkins Medicine in the United States, and those with interpretation needs. JHI also leverages Johns Hopkins’ extensive knowledge base in medicine, nursing, public health, medical education, research and health care administration to improve health care delivery through sustainable, high-impact collaborations throughout the world. More information is available at

About National Healthcare Group
NHG is a leader in public health care in Singapore, recognized at home and abroad for the quality of its medical expertise and facilities. Care is provided through an integrated network of six primary care polyclinics, acute care and tertiary hospitals, national specialty centers and business divisions. Together they bring a rich legacy of medical expertise to our philosophy of integrated patient-centered care. NHG’s vision is “Adding Years of Healthy Life.” This vision goes beyond merely healing the sick to the more difficult and infinitely more rewarding task of preventing illness and preserving health and quality of life. NHG aims to provide care that is patient-centric, accessible, seamless, comprehensive, appropriate and cost effective. As the Regional Health System (RHS) for Singapore, it is vital for NHG to partner and collaborate with stakeholders, community advisors and voluntary welfare organizations. Together with our patients, their families and caregivers, we aim to deliver integrated health care services and programs that help in Adding Years of Healthy Life. More information is available at

About Tan Tock Seng Hospital
TTSH is one of Singapore’s largest multidisciplinary hospitals, with 173 years of pioneering medical care and development. The hospital has 45 clinical and allied health departments and 16 specialist centers. It also has three institutes that are spearheading care, research and innovations in geriatric medicine, infectious diseases and ophthalmology. Powered by more than 8,000 health care staff, TTSH sees over 2,500 patients at its specialist clinics and some 460 patients at its emergency department every day. TTSH is part of the National Healthcare Group, providing holistic and integrated patient care. With a strong quality culture steeped in patient safety, TTSH constantly challenges itself to provide faster, better, cheaper and safer care for patients. To achieve this, the hospital keeps abreast and believes in investing in its staff, facilities, medical technology and system improvements. More information is available at